Wegovy craze was all the rage on Q3 earnings calls

Retail investors crowd into Eli Lilly after weight-loss drug approval

Wegovy's heart benefits due to more than weight loss, Novo says

Eli Lilly: still seeking UK approval on pen for weight-loss drug

Weight loss drugs transforming healthcare, may help with addiction -Reuters Events

Factbox-Corporate America weighs risks of the Ozempic effect

Novo Nordisk's Wegovy bonanza looms large in Denmark

U.S. FDA found lapses at Novo's main U.S. factory in May 2022 -report

Wegovy makes UK weight-loss debut even as Novo struggles with supplies

Obesity drug data could boost companies' case for US coverage-analysts

Novo Nordisk weight-loss drug Wegovy launched in Germany, first big EU market

Lilly's obesity drug leads to about 26% weight loss in new studies